Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapyJieping Lei, Veli‐Matti Kosma, Sabine Behrens et al.|Breast Cancer Research|2015Cited by 24
Heterogeneity of macrophage-activating factors (MAFs) and their effects in vivo.Peter H. Krammer, William A. Müller, Diethard Gemsa et al.|PubMed|1984Cited by 1